Mechanisms of Hedgehog signaling in glioblastoma

胶质母细胞瘤中 Hedgehog 信号传导机制

基本信息

项目摘要

Project summary Glioblastomas are deadly tumors and account for approximately half of all malignant primary brain cancers. Glioblastoma stem cells exist in interchangeable cellular states that are influenced by the tumor microenvironment, and there is a paucity of information concerning the cellular mechanisms responsible for communicating between glioblastoma cells and the tumor stroma. The Hedgehog pathway, which directs gene expression programs that are essential for development and adult stem cell homeostasis, is critical for survival of glioblastoma stem cells. Paradoxically, a clinical trial suggested that pharmacologic inhibition of the Hedgehog pathway accelerates glioblastoma growth. These clinical data provide an opportunity to re-evaluate how the Hedgehog pathway functions in cancer, and suggest that the role of Hedgehog signaling in glioblastoma stem cells remains to be elucidated. This proposal focuses on understanding how inhibition of the Hedgehog pathway drives glioblastoma at the tumor, cellular, and molecular scale. To do so, our proposal incorporates a novel astrocyte organoid model of glioblastoma that facilitates live imaging of cellular interactions within the tumor microenvironment. When integrated with CRISPR interference, pharmacology, and mouse syngeneic and patient derived xenograft models of glioblastoma, our innovative organoid system will facilitate previously impossible experiments to understand glioblastoma biology. Based on our preliminary organoid, in vivo, and single cell RNA sequencing data presented in this application, we hypothesize that cancer cell-extrinsic Hedgehog signaling in the tumor microenvironment restrains glioblastoma stem cell-renewal and invasion by inducing differentiation factors and remodeling the extracellular matrix. We will test this hypothesis by defining how Hedgehog signals are transduced through the glioblastoma microenvironment; determining if cancer-cell extrinsic Hedgehog signaling restrains glioblastoma stem cells by inducing bone morphogenic protein signaling; and determining if Hedgehog signaling restrains glioblastoma cell invasion by inducing genes that regulate migration through the extracellular matrix. This approached is based on the premise that by studying the mechanisms of Hedgehog signaling in glioblastoma, we will discover new insights into how glioblastoma cells communicate with the tumor microenvironment. Indeed, we know surprisingly little about how interactions between glioblastoma cells and the tumor microenvironment influence cancer progression, and almost nothing about how astrocytes, which comprise the majority of cell types in the adult brain, influence glioblastoma invasion or tumorigenesis. Though the objective of this proposal is to broadly improve our understanding of the mechanisms of Hedgehog signaling in glioblastoma, a long-term goal of this research is to understand these processes well enough to consider targeted therapeutic strategies to improve survival from glioblastoma. Thus, this work will explain why Hedgehog pathway inhibition unexpectedly accelerates glioblastoma growth, elucidate targetable mechanisms, and provide the preclinical basis for new clinical trials in glioblastoma patients.
项目摘要 胶质母细胞瘤是致命的肿瘤,约占所有恶性原发性脑癌的一半。 胶质母细胞瘤干细胞存在于受肿瘤影响的可互换的细胞状态中 微环境,并且缺乏有关细胞机制的信息, 在胶质母细胞瘤细胞和肿瘤间质之间进行沟通。Hedgehog途径,它指导基因 对于发育和成体干细胞稳态至关重要的表达程序, 胶质母细胞瘤干细胞。自相矛盾的是,一项临床试验表明,对刺猬的药物抑制作用 加速胶质母细胞瘤的生长。这些临床数据提供了一个重新评估 Hedgehog通路在癌症中发挥作用,并表明Hedgehog信号传导在胶质母细胞瘤干细胞中的作用。 细胞仍有待进一步研究。这项提案的重点是了解如何抑制刺猬途径 在肿瘤、细胞和分子水平上驱动胶质母细胞瘤。为了做到这一点,我们的建议包括一本小说, 胶质母细胞瘤的星形胶质细胞类器官模型,有助于肿瘤内细胞相互作用的实时成像 微环境当与CRISPR干扰、药理学和小鼠同基因和 患者来源的胶质母细胞瘤异种移植模型,我们的创新类器官系统将促进以前的 不可能的实验来了解胶质母细胞瘤的生物学。基于我们初步的类器官,在体内, 本申请中提供的单细胞RNA测序数据,我们假设癌细胞-外源性 肿瘤微环境中的Hedgehog信号通过抑制胶质母细胞瘤干细胞的更新和侵袭 诱导分化因子和重塑细胞外基质。我们将通过定义以下内容来检验这一假设: Hedgehog信号是如何通过胶质母细胞瘤微环境转导的;确定癌细胞 外源性Hedgehog信号通过诱导骨形态发生蛋白信号抑制胶质母细胞瘤干细胞; 并确定Hedgehog信号传导是否通过诱导调节胶质母细胞瘤细胞侵袭的基因, 通过细胞外基质迁移。这种方法的前提是,通过研究 Hedgehog信号在胶质母细胞瘤中的作用机制,我们将发现胶质母细胞瘤细胞 与肿瘤微环境沟通。事实上,我们对相互作用 胶质母细胞瘤细胞和肿瘤微环境之间的联系影响癌症的进展, 关于星形胶质细胞如何影响胶质母细胞瘤的侵袭, 或肿瘤发生。虽然这项建议的目的是广泛地提高我们对 Hedgehog信号在胶质母细胞瘤中的作用机制,这项研究的长期目标是了解这些 这一过程足以考虑靶向治疗策略,以提高胶质母细胞瘤的生存率。因此,在本发明中, 这项工作将解释为什么Hedgehog通路抑制意外地加速胶质母细胞瘤的生长,阐明 靶向机制,并为胶质母细胞瘤患者的新临床试验提供临床前基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David R Raleigh其他文献

David R Raleigh的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David R Raleigh', 18)}}的其他基金

Biochemical mechanisms of Hedgehog signal transduction through primary cilia
Hedgehog通过初级纤毛信号转导的生化机制
  • 批准号:
    10447446
  • 财政年份:
    2022
  • 资助金额:
    $ 53.45万
  • 项目类别:
Biochemical mechanisms of Hedgehog signal transduction through primary cilia
Hedgehog通过初级纤毛信号转导的生化机制
  • 批准号:
    10570940
  • 财政年份:
    2022
  • 资助金额:
    $ 53.45万
  • 项目类别:
Understanding druggable drivers of meningioma tumorigenesis
了解脑膜瘤肿瘤发生的药物驱动因素
  • 批准号:
    10663243
  • 财政年份:
    2021
  • 资助金额:
    $ 53.45万
  • 项目类别:
Understanding druggable drivers of meningioma tumorigenesis
了解脑膜瘤肿瘤发生的药物驱动因素
  • 批准号:
    10456201
  • 财政年份:
    2021
  • 资助金额:
    $ 53.45万
  • 项目类别:
Mechanisms of Hedgehog signaling in glioblastoma
胶质母细胞瘤中 Hedgehog 信号传导机制
  • 批准号:
    10373062
  • 财政年份:
    2021
  • 资助金额:
    $ 53.45万
  • 项目类别:
Understanding druggable drivers of meningioma tumorigenesis
了解脑膜瘤肿瘤发生的药物驱动因素
  • 批准号:
    10275399
  • 财政年份:
    2021
  • 资助金额:
    $ 53.45万
  • 项目类别:
Mechanisms of Hedgehog signaling in glioblastoma
胶质母细胞瘤中 Hedgehog 信号传导机制
  • 批准号:
    10608976
  • 财政年份:
    2021
  • 资助金额:
    $ 53.45万
  • 项目类别:
Understanding How Ciliary Hedgehog Signaling Causes Medulloblastoma
了解睫状刺猬信号如何导致髓母细胞瘤
  • 批准号:
    10196981
  • 财政年份:
    2017
  • 资助金额:
    $ 53.45万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 53.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 53.45万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 53.45万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 53.45万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 53.45万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 53.45万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 53.45万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 53.45万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 53.45万
  • 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
  • 批准号:
    23K05057
  • 财政年份:
    2023
  • 资助金额:
    $ 53.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了